CSE's Barrington Miller is joined by Anthony Durkacz, Interim CEO of FSD Pharma (CSE:HUGE) to discuss the company's recent history and transition from the cannabis-era to new opportunities in the growing psychedelics space.
Here's an overview of what Barrington and Anthony discuss in this edition of the "Exchange for Entrepreneurs" podcast:
0:00 – Introducing Anthony Durkacz, Interim CEO of FSD Pharma
5:45 – Working back towards a 1Bn market cap
8:10 – The latest investment in Lucid Psycheceuticals Inc. and treating MS
10:50 – The psychedelics movement
14:13 – Listing on NASDAQ
Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe
STAY CONNECTED WITH THE CSE
=============================
– PODCAST: https://blog.thecse.com/cse-podcasts/
– INSTAGRAM: https://www.instagram.com/canadianexchange/
– LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange
– FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/
– TWITTER: https://twitter.com/CSE_News
– BLOG: https://blog.thecse.com/
– WEBSITE: https://thecse.com/
Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe
More from The CSE Podcast
2026 Federal Budget: Do Public Companies Benefit? with Richard CarletonThe CSE PodcastNov 20, 2026, 16 min

